BCL6 and cancer: The binding between B-cell lymphoma 6 protein (BCL6) and genome can recruit diverse chromatin-modifying co-repressor complexes to inhibit gene expression, in order to promote tumorigenesis and cancer progression, such as DNA damage sensing and proliferation checkpoints [44].